Skip to main content
Top
Published in: Infection 1/2016

01-02-2016 | Original Paper

Clinical features and outcome of patients with descending necrotizing mediastinitis: prospective analysis of 34 cases

Authors: Daniela M. Palma, Simone Giuliano, Andrea N. Cracchiolo, Marco Falcone, Giancarlo Ceccarelli, Romano Tetamo, Mario Venditti

Published in: Infection | Issue 1/2016

Login to get access

Abstract

Purpose

We aimed to investigate clinical features of patients with descending necrotizing mediastinitis (DNM) in order to improve management and outcome.

Methods

We prospectively examined all patients with DNM admitted to the Intensive Care Unit (ICU) during the period from April 2007 to December 2013. Demographics, clinical features, microbiology, medical and surgical treatment data were recorded. Survivor and nonsurvivor groups were analyzed to identify factors associated with mortality.

Results

Overall, 34 patients with DNM have been included. The mean age was 46.8 ± 11.2 years (range 24–70). The male/female ratio was 3.25. DNM arose from odontogenic infection in 22 (65 %) patients; from peritonsillar abscess in 9 (26 %) patients and from paranasal sinus in 3 (9 %) patients. Microbiological cultures revealed a high percentage of aerobic/anaerobic coinfection. Nonsurvivors were statistically more likely to have higher SAPS II score (mean difference 19.1, 95 % CI 12.3–25.9 P < 0.01) and more severe disease (P < 0.01) than survivors. Positive correlation was found between time to ICU admission after head or neck infection diagnosis and SAPS II score (ρ = 0.5, P = 0.03). The same was true for ICU length of stay and time to ICU admission (ρ = 0.6, P < 0.01) and time to surgery (ρ = 0.5, P = 0.03). Surgical treatments consisted in: transcervical drainage in 14 cases, (42 %); irrigation through subxiphoid and cervical incisions of the anterior mediastinum with additional percutaneous thoracic drainage when necessary in ten cases, (29 %); thoracotomy with radical mediastinal surgical debridement, excision of necrotic tissue and decortication in ten cases, (29 %). We have found a mortality rate of 12 %. Patients with DNM type IIB were admitted to the ICU later than patients with DNM type I and type IIA (mean difference 3.2 days, 95 % CI 1.2–5.1, P 0.02).

Conclusions

Prompt ICU admission in order to manage severe sepsis and/or septic shock, along with early and aggressive surgery and adequate antimicrobial therapy, could be key factors in reducing DNM mortality.
Literature
1.
go back to reference Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis. 1995;21:51–6.CrossRefPubMed Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis. 1995;21:51–6.CrossRefPubMed
2.
go back to reference Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987;206:661–5.PubMedCentralCrossRefPubMed Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987;206:661–5.PubMedCentralCrossRefPubMed
3.
go back to reference Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.CrossRefPubMed Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.CrossRefPubMed
5.
go back to reference Mandell GL, Bennet JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practise of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2007. Mandell GL, Bennet JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practise of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2007.
6.
go back to reference Kocher GJ, Hoksch B, Caversaccio M, Wiegand J, Schmid RA. Diffuse descending necrotizing mediastinitis: surgical therapy and outcome in a single-centre series. Eur J Cardiothorac Surg. 2012;42:e66–72. doi:10.1093/ejcts/ezs385.CrossRefPubMed Kocher GJ, Hoksch B, Caversaccio M, Wiegand J, Schmid RA. Diffuse descending necrotizing mediastinitis: surgical therapy and outcome in a single-centre series. Eur J Cardiothorac Surg. 2012;42:e66–72. doi:10.​1093/​ejcts/​ezs385.CrossRefPubMed
7.
go back to reference Estrera AS, Landay MJ, Grisham JM, Sinn DP, Platt MR. Descending necrotizing mediastinitis. Surg Gynecol Obstet. 1983;157:545–52.PubMed Estrera AS, Landay MJ, Grisham JM, Sinn DP, Platt MR. Descending necrotizing mediastinitis. Surg Gynecol Obstet. 1983;157:545–52.PubMed
8.
go back to reference Levine TM, Wurster CF, Krespi YP. Mediastinitis occurring as a complication of odontogenic infections. Laryngoscope. 1986;96:747–50.PubMed Levine TM, Wurster CF, Krespi YP. Mediastinitis occurring as a complication of odontogenic infections. Laryngoscope. 1986;96:747–50.PubMed
10.
go back to reference Roccia F, Pecorari GC, Oliaro A, et al. Ten years of descending necrotizing mediastinitis: management of 23 cases. J Oral Maxillofac Surg. 2007;65:1716–24.CrossRefPubMed Roccia F, Pecorari GC, Oliaro A, et al. Ten years of descending necrotizing mediastinitis: management of 23 cases. J Oral Maxillofac Surg. 2007;65:1716–24.CrossRefPubMed
11.
go back to reference Guardia SN, Cameron R, Phillips A. Fatal necrotizing mediastinitis secondary to acute suppurative parotitis. J Otolaryngol. 1991;20:54–6.PubMed Guardia SN, Cameron R, Phillips A. Fatal necrotizing mediastinitis secondary to acute suppurative parotitis. J Otolaryngol. 1991;20:54–6.PubMed
12.
go back to reference Endo S, Murayama F, Hasegawa T, et al. Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg. 1999;47:14–9.CrossRefPubMed Endo S, Murayama F, Hasegawa T, et al. Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg. 1999;47:14–9.CrossRefPubMed
13.
go back to reference Wheatley MJ, Stirling MC, Kirsh MM, Gago O, Orringer MB. Descending necrotizing mediastinitis: transcervical drainage is not enough. Ann Thorac Surg. 1990;49:780–4.CrossRefPubMed Wheatley MJ, Stirling MC, Kirsh MM, Gago O, Orringer MB. Descending necrotizing mediastinitis: transcervical drainage is not enough. Ann Thorac Surg. 1990;49:780–4.CrossRefPubMed
14.
go back to reference Kiernan PD, Hernandez A, Byrne WD, et al. Descending cervical mediastinitis. Ann Thorac Surg. 1998;65:1483–8.CrossRefPubMed Kiernan PD, Hernandez A, Byrne WD, et al. Descending cervical mediastinitis. Ann Thorac Surg. 1998;65:1483–8.CrossRefPubMed
15.
go back to reference Scaglione M, Pinto A, Romano S, Giovine S, Sparano A, Romano L. Determining optimum management of descending necrotizing mediastinitis with CT; experience with 32 cases. Emerg Radiol. 2005;11:275–80.CrossRefPubMed Scaglione M, Pinto A, Romano S, Giovine S, Sparano A, Romano L. Determining optimum management of descending necrotizing mediastinitis with CT; experience with 32 cases. Emerg Radiol. 2005;11:275–80.CrossRefPubMed
16.
go back to reference Suehara AB, Gonçalves AJ, Alcadipani FA, Kavabata NK, Menezes MB. Deep neck infection: analysis of 80 cases. Braz J Otorhinolaryngol. 2008;74:253–9.CrossRefPubMed Suehara AB, Gonçalves AJ, Alcadipani FA, Kavabata NK, Menezes MB. Deep neck infection: analysis of 80 cases. Braz J Otorhinolaryngol. 2008;74:253–9.CrossRefPubMed
18.
go back to reference Pellis T, Berlot G, Giacomarra V, Bregant M. Descending necrotizing mediastinitis. Clinical experience and review of the literature. Minerva Anestesiol. 2001;67:731–6.PubMed Pellis T, Berlot G, Giacomarra V, Bregant M. Descending necrotizing mediastinitis. Clinical experience and review of the literature. Minerva Anestesiol. 2001;67:731–6.PubMed
19.
go back to reference Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotize fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535–41.CrossRefPubMed Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotize fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535–41.CrossRefPubMed
20.
go back to reference Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen year retrospective study of 163 consecutive patients. Am Surg. 2002;68:109–16.PubMed Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen year retrospective study of 163 consecutive patients. Am Surg. 2002;68:109–16.PubMed
21.
go back to reference Makeieff M, Gresillon N, Berthet JP, et al. Management of descending necrotizing mediastinitis. Laryngoscope. 2004;114:772–5.CrossRefPubMed Makeieff M, Gresillon N, Berthet JP, et al. Management of descending necrotizing mediastinitis. Laryngoscope. 2004;114:772–5.CrossRefPubMed
23.
go back to reference Moncada R, Warpeha R, Pickleman J, et al. Mediastinitis from odontogenic and deep cervical infection. Anatomic pathways of propagation. Chest. 1978;73:497–500.CrossRefPubMed Moncada R, Warpeha R, Pickleman J, et al. Mediastinitis from odontogenic and deep cervical infection. Anatomic pathways of propagation. Chest. 1978;73:497–500.CrossRefPubMed
24.
25.
go back to reference Cainzos M, Gonzalez-Rodriguez J. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13:433–9.CrossRefPubMed Cainzos M, Gonzalez-Rodriguez J. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13:433–9.CrossRefPubMed
26.
go back to reference Goldstein EJC, Anaya DA, Patchen Dellinger E. Necrotizing soft tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.CrossRef Goldstein EJC, Anaya DA, Patchen Dellinger E. Necrotizing soft tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.CrossRef
27.
go back to reference Lavini C, Natali P, Morandi U, Dallari S, Bergamini G. Descending necrotizing mediastinitis. Diagnosis and surgical treatment. J Cardiovasc Surg. 2003;44:655–60. Lavini C, Natali P, Morandi U, Dallari S, Bergamini G. Descending necrotizing mediastinitis. Diagnosis and surgical treatment. J Cardiovasc Surg. 2003;44:655–60.
28.
go back to reference Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fascitiis: clinical presentation, microbiology and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454–60.PubMed Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fascitiis: clinical presentation, microbiology and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454–60.PubMed
29.
go back to reference Bilton BD, Zibari GB, Mc Millan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fascitiis serves to decrease mortality: a retrospective study. Am Surg. 1998;64:397–400.PubMed Bilton BD, Zibari GB, Mc Millan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fascitiis serves to decrease mortality: a retrospective study. Am Surg. 1998;64:397–400.PubMed
30.
go back to reference Mitjans MS, Sanchís JB, Padro XB, García I, Garolera JM, Garay MR. Descending necrotizing mediastinitis. Int Surg. 2000;85:331–5.PubMed Mitjans MS, Sanchís JB, Padro XB, García I, Garolera JM, Garay MR. Descending necrotizing mediastinitis. Int Surg. 2000;85:331–5.PubMed
31.
go back to reference Arabi Y, Haddad S, Shirawi N, Al Shimemeri A. Early tracheostomy in intensive care trauma patients improves resource utilization: a cohort study and literature review. Crit Care. 2004;8:R347–52.PubMedCentralCrossRefPubMed Arabi Y, Haddad S, Shirawi N, Al Shimemeri A. Early tracheostomy in intensive care trauma patients improves resource utilization: a cohort study and literature review. Crit Care. 2004;8:R347–52.PubMedCentralCrossRefPubMed
32.
go back to reference Pierson DJ. Tracheostomy and weaning. Respir Care. 2005;50:526–33.PubMed Pierson DJ. Tracheostomy and weaning. Respir Care. 2005;50:526–33.PubMed
34.
go back to reference Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev. 1994;13:65–74.CrossRefPubMed Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev. 1994;13:65–74.CrossRefPubMed
35.
go back to reference LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2004;48:4665–72.PubMedCentralCrossRefPubMed LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2004;48:4665–72.PubMedCentralCrossRefPubMed
37.
go back to reference Palacio F, Lewis JS 2nd, Sadkowski L, Echevarria K, Jorgensen JH. Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy. Antimicrob Agents Chemother. 2011;55:3639–40. doi:10.1128/AAC.00231-11.PubMedCentralCrossRefPubMed Palacio F, Lewis JS 2nd, Sadkowski L, Echevarria K, Jorgensen JH. Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy. Antimicrob Agents Chemother. 2011;55:3639–40. doi:10.​1128/​AAC.​00231-11.PubMedCentralCrossRefPubMed
39.
go back to reference Dhand A, Bayer AS, Pogliano J, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53:158–63. doi:10.1093/cid/cir340.PubMedCentralCrossRefPubMed Dhand A, Bayer AS, Pogliano J, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53:158–63. doi:10.​1093/​cid/​cir340.PubMedCentralCrossRefPubMed
40.
go back to reference English BK, Maryniw EM, Talati AJ. Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob Agents Chemother. 2006;50:2225–7.PubMedCentralCrossRefPubMed English BK, Maryniw EM, Talati AJ. Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob Agents Chemother. 2006;50:2225–7.PubMedCentralCrossRefPubMed
41.
go back to reference Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–92.CrossRefPubMed Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–92.CrossRefPubMed
42.
go back to reference Falcone M, Russo A, Venditti M. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature. J Infect Chemother. 2015;21:330–9.CrossRefPubMed Falcone M, Russo A, Venditti M. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature. J Infect Chemother. 2015;21:330–9.CrossRefPubMed
43.
go back to reference Falcone M, Russo A, Venditti M, Novelli A, Pai MP. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57:1568–76.CrossRefPubMed Falcone M, Russo A, Venditti M, Novelli A, Pai MP. Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57:1568–76.CrossRefPubMed
44.
go back to reference Falcone M, Russo A, Cassetta MI, et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? J Infect Chemother. 2013;19:732–9.CrossRefPubMed Falcone M, Russo A, Cassetta MI, et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? J Infect Chemother. 2013;19:732–9.CrossRefPubMed
Metadata
Title
Clinical features and outcome of patients with descending necrotizing mediastinitis: prospective analysis of 34 cases
Authors
Daniela M. Palma
Simone Giuliano
Andrea N. Cracchiolo
Marco Falcone
Giancarlo Ceccarelli
Romano Tetamo
Mario Venditti
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0838-y

Other articles of this Issue 1/2016

Infection 1/2016 Go to the issue